Table 2:
Open in new tab

Rate of bleeders and Utah Bleeding Risk Score of bleeders and non-bleeders

Bleeders, n (%)
 Within 3 years after CF-LVAD implantation (3 years)28 (25)
 During whole support time (st)30 (27)
Utah Bleeding Risk Score, median (IQR)
 Bleeders2 (3-1)
 Non-bleeders2 (3-1)
Bleeders, n (%)
 Within 3 years after CF-LVAD implantation (3 years)28 (25)
 During whole support time (st)30 (27)
Utah Bleeding Risk Score, median (IQR)
 Bleeders2 (3-1)
 Non-bleeders2 (3-1)

CF-LVAD: continuous-flow left ventricular assist devices; IQR: interquartile range.

Table 2:
Open in new tab

Rate of bleeders and Utah Bleeding Risk Score of bleeders and non-bleeders

Bleeders, n (%)
 Within 3 years after CF-LVAD implantation (3 years)28 (25)
 During whole support time (st)30 (27)
Utah Bleeding Risk Score, median (IQR)
 Bleeders2 (3-1)
 Non-bleeders2 (3-1)
Bleeders, n (%)
 Within 3 years after CF-LVAD implantation (3 years)28 (25)
 During whole support time (st)30 (27)
Utah Bleeding Risk Score, median (IQR)
 Bleeders2 (3-1)
 Non-bleeders2 (3-1)

CF-LVAD: continuous-flow left ventricular assist devices; IQR: interquartile range.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close